Page last updated: 2024-12-06
n-(3-aminopropyl)cyclohexylamine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 18718 |
| SCHEMBL ID | 27221 |
| MeSH ID | M0216604 |
Synonyms (58)
| Synonym |
|---|
| BIO1_001426 |
| BIO1_000448 |
| BIO1_000937 |
| 3312-60-5 |
| 1, n-cyclohexyl- |
| nsc87572 |
| 1-(cyclohexylamino)-3-aminopropane |
| n-cyclohexylpropylene-1,3-diamine |
| nsc-87572 |
| n-(3-aminopropyl)cyclohexylamine |
| cyclohexylamine, n-(3-aminopropyl)- |
| n-cyclohexyl-1,3-propanediamine |
| cyclohexyl-1,3-propanediamine |
| n-cyclohexyl-1,3-propylenediamine |
| 3-(aminopropyl)cyclohexylamine |
| 3-(cyclohexylamino)-1-propylamine |
| n-cyclohexyl-1,3-diaminopropane |
| PDSP1_000332 |
| PDSP2_000330 |
| n-cyclohexyl-1,3-propanediamine, 99% |
| A0891 |
| n-cyclohexylpropylene 1,3-diamine |
| n'-cyclohexylpropane-1,3-diamine |
| AKOS000120145 |
| 1,3-propanediamine, n1-cyclohexyl- |
| 3-cyclohexylaminopropylamine |
| 1,3-propanediamine, n-cyclohexyl- |
| nsc 87572 |
| unii-f4xob09fkn |
| einecs 222-001-7 |
| f4xob09fkn , |
| n1-cyclohexylpropane-1,3-diamine |
| cas_3312-60-5 |
| aminopropyl-cyclohexylamine |
| bdbm86157 |
| FT-0629166 |
| 3-(cyclohexylamino)propylamine |
| (cyclohexylamino)propylamine |
| n-(3-aminopropyl)-n-cyclohexylamine |
| 3-amino-1-(cyclohexylamino)propane |
| n-cyclohexyltrimethylenediamine |
| SCHEMBL27221 |
| n-1-cyclohexyl-propane-1,3-diamine |
| 3-cyclohexylamino-1-propylamine |
| DTXSID6062969 |
| n-cyclohexyl trimethylene diamine |
| n-cyclohexylpropane-1,3-diamine |
| mfcd00003838 |
| J-019035 |
| n1-cyclohexyl-1,3-propanediamine |
| 3-aminocyclohexylaminopropane |
| CS-W016230 |
| Q27277640 |
| A875416 |
| n-(3-aminopropyl)cyclohexylamine; n-cyclohexyl-1,3-diaminopropane~n-cyclohexyl-1,3-propanediamine |
| D84281 |
| EN300-20614 |
| HY-W015514 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (10)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 11.94
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.94) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||